SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sotera Health Sees 2021 Revenue at High End of Guidance Range

01/11/2022 | 07:31am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ON SEMICONDUCTOR CORPORATION 3.19% 56.24 Delayed Quote.-17.20%
SOTERA HEALTH COMPANY 0.69% 20.49 Delayed Quote.-12.99%
All news about SOTERA HEALTH COMPANY
05:10pClover Health Investments Appoints Scott Leffler as CFO
MT
05/19SOTERA HEALTH : Announces Departure of Chief Financial Officer Scott Leffler - Form 8-K
PU
05/19Sotera Health CFO Scott Leffler to Depart
MT
05/19SOTERA HEALTH CO : Change in Directors or Principal Officers, Regulation FD Disclosure, Fi..
AQ
05/19Sotera Health Announces Departure of Chief Financial Officer Scott Leffler
GL
05/19Sotera Health Announces Departure of Chief Financial Officer Scott Leffler
GL
05/19Sotera Health Company Announces Departure of Scott Leffler as Chief Financial Officer, ..
CI
05/19Sterigenics Announces Increased Electron Beam Sterilization Capacity to Support Health..
GL
05/19Sterigenics Announces Increased Electron Beam Sterilization Capacity to Support Health..
AQ
05/17TRANSCRIPT : Sotera Health Company Presents at RBC Capital Markets Global Healthcare Confe..
CI
More news
Analyst Recommendations on SOTERA HEALTH COMPANY
More recommendations
Financials (USD)
Sales 2022 1 020 M - -
Net income 2022 174 M - -
Net Debt 2022 1 430 M - -
P/E ratio 2022 33,0x
Yield 2022 -
Capitalization 5 795 M 5 795 M -
EV / Sales 2022 7,08x
EV / Sales 2023 6,37x
Nbr of Employees 3 000
Free-Float 96,0%
Chart SOTERA HEALTH COMPANY
Duration : Period :
Sotera Health Company Technical Analysis Chart | SHC | US83601L1026 | MarketScreener
Technical analysis trends SOTERA HEALTH COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 20,49 $
Average target price 27,00 $
Spread / Average Target 31,8%
EPS Revisions
Managers and Directors
Michael B. Petras Chief Executive Officer
Scott J. Leffler Chief Financial Officer & Treasurer
Robert G. Hauzie Chief Information Officer
Sean Laurence Cunningham Independent Director
Dave Anthony Donnini Independent Director